Loading chart…
PRE-MARKET
Beta Drugs Limited develops, manufactures, and sells anti-cancer bulk drugs and finished dosages in India. The company offers cosmeceutical and oncology products. It also manufactures active pharmaceutical ingredients (API) and pharmaceutical formulation intermediates (PFI).
Beta Drugs Limited (BETA) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The BETA share price is ₹1,819.00 (-1.18% today), with a market capitalisation of ₹18B and a price-to-earnings (P/E) ratio of 26.8. MarketRipple tracks the BETA investment thesis, the ripple-chain impact of market events on Beta Drugs Limited, and the Healthcare sector outlook.
Open
₹1,807.00
High
₹1,855.90
Low
₹1,807.00
Prev. Close
₹1,840.70
52W High
₹2,807.90
52W Low
₹990.10
Day range
₹1,807.00–₹1,855.90
52-week range
₹990.10–₹2,807.90
Volume
4K
P/E
26.8
ROE
16.9%
D/E
0.60
Margin
11.1%
Beta Drugs Limited (NSE: BETA) is currently trading at ₹1,819.00 (-1.18%).
Beta Drugs Limited's market capitalization is ₹18B.
Beta Drugs Limited's price-to-earnings (P/E) ratio is 26.8.
Beta Drugs Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).